메뉴 건너뛰기




Volumn 106, Issue 2, 2010, Pages

Comparison by meta-analysis of eptifibatide and tirofiban to abciximab in patients with st-elevation myocardial infarction treated with primary percutaneous coronary intervention

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; EPTIFIBATIDE; TIROFIBAN;

EID: 77955694874     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.03.012     Document Type: Article
Times cited : (32)

References (24)
  • 1
    • 0037417523 scopus 로고    scopus 로고
    • Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials
    • E. Keeley, J. Boura, and C. Grines Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials Lancet 361 2003 3 20
    • (2003) Lancet , vol.361 , pp. 3-20
    • Keeley, E.1    Boura, J.2    Grines, C.3
  • 2
    • 4444384038 scopus 로고    scopus 로고
    • Abciximab-supported infarct artery stent implantation for acute myocardial infarction and long-term survival: A prospective, multicenter, randomized trial comparing infarct artery stenting plus abciximab with stenting alone
    • D. Antoniucci, A. Migliorini, G. Parodi, R. Valenti, A. Rodriguez, A. Hempel, G. Memisha, and G.M. Santoro Abciximab-supported infarct artery stent implantation for acute myocardial infarction and long-term survival: a prospective, multicenter, randomized trial comparing infarct artery stenting plus abciximab with stenting alone Circulation 109 2004 1704 1706
    • (2004) Circulation , vol.109 , pp. 1704-1706
    • Antoniucci, D.1    Migliorini, A.2    Parodi, G.3    Valenti, R.4    Rodriguez, A.5    Hempel, A.6    Memisha, G.7    Santoro, G.M.8
  • 4
    • 16444368352 scopus 로고    scopus 로고
    • Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: A meta-analysis of randomized trials
    • G. De Luca, H. Suryapranata, G.W. Stone, D. Antoniucci, J.E. Tcheng, F.J. Neumann, F. Van de Werf, E.M. Antman, and E.J. Topol Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials JAMA 293 2005 1759 1765
    • (2005) JAMA , vol.293 , pp. 1759-1765
    • De Luca, G.1    Suryapranata, H.2    Stone, G.W.3    Antoniucci, D.4    Tcheng, J.E.5    Neumann, F.J.6    Van De Werf, F.7    Antman, E.M.8    Topol, E.J.9
  • 5
    • 3042654898 scopus 로고    scopus 로고
    • Comparison in patients having primary angioplasty of abciximab versus tirofiban on recovery of left ventricular function
    • G. Danzi, M. Sesana, C. Capuano, L. Mauri, P. Centurini, and R. Baglini Comparison in patients having primary angioplasty of abciximab versus tirofiban on recovery of left ventricular function Am J Cardiol 94 2004 35 39
    • (2004) Am J Cardiol , vol.94 , pp. 35-39
    • Danzi, G.1    Sesana, M.2    Capuano, C.3    Mauri, L.4    Centurini, P.5    Baglini, R.6
  • 8
    • 34147144861 scopus 로고    scopus 로고
    • Clinical outcomes comparing eptifibatide and abciximab in ST elevation acute myocardial infarction patients undergoing percutaneous coronary interventions
    • M.G. Midei, V.J. Coombs, D.R. Lowry, M.N. Drossner, K.C. Prewitt, J.C. Wang, M.B. Loughrey, and S.O. Gottlieb Clinical outcomes comparing eptifibatide and abciximab in ST elevation acute myocardial infarction patients undergoing percutaneous coronary interventions Cardiology 107 2007 172 177
    • (2007) Cardiology , vol.107 , pp. 172-177
    • Midei, M.G.1    Coombs, V.J.2    Lowry, D.R.3    Drossner, M.N.4    Prewitt, K.C.5    Wang, J.C.6    Loughrey, M.B.7    Gottlieb, S.O.8
  • 13
    • 0035802760 scopus 로고    scopus 로고
    • Extent of ST-segment deviation in a single electrocardiogram lead 90 min after thrombolysis as a predictor of medium-term mortality in acute myocardial infarction
    • K. Schrder, K. Wegscheider, U.T. Zeymer, and R. Schrder Extent of ST-segment deviation in a single electrocardiogram lead 90 min after thrombolysis as a predictor of medium-term mortality in acute myocardial infarction Lancet 358 2001 1479 1486
    • (2001) Lancet , vol.358 , pp. 1479-1486
    • Schrder, K.1    Wegscheider, K.2    Zeymer, U.T.3    Schrder, R.4
  • 14
    • 34548359246 scopus 로고    scopus 로고
    • Abciximab in primary coronary stenting of ST-elevation myocardial infarction: A European meta-analysis on individual patients' data with long-term follow-up
    • G. Montalescot, D. Antoniucci, A. Kastrati, F.J. Neumann, M. Borentain, A. Migliorini, C. Boutron, J.P. Collet, and E. Vicaut Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patients' data with long-term follow-up Eur Heart J 28 2007 443 449
    • (2007) Eur Heart J , vol.28 , pp. 443-449
    • Montalescot, G.1    Antoniucci, D.2    Kastrati, A.3    Neumann, F.J.4    Borentain, M.5    Migliorini, A.6    Boutron, C.7    Collet, J.P.8    Vicaut, E.9
  • 15
  • 16
    • 0041876133 scopus 로고    scopus 로고
    • Measuring inconsistency in meta-analyses
    • J. Higgins, S. Thompson, J. Deeks, and D. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560
    • (2003) BMJ , vol.327 , pp. 557-560
    • Higgins, J.1    Thompson, S.2    Deeks, J.3    Altman, D.4
  • 17
    • 0033934949 scopus 로고    scopus 로고
    • Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis
    • S. Duval, and R. Tweedie Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis Biometrics 56 2000 455 463
    • (2000) Biometrics , vol.56 , pp. 455-463
    • Duval, S.1    Tweedie, R.2
  • 18
    • 69149107165 scopus 로고    scopus 로고
    • Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
    • D. Moher, A. Liberati, J. Tetzlaff, and D. Altman Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Ann Intern Med 151 2009 264 269
    • (2009) Ann Intern Med , vol.151 , pp. 264-269
    • Moher, D.1    Liberati, A.2    Tetzlaff, J.3    Altman, D.4
  • 21
    • 31944443998 scopus 로고    scopus 로고
    • Variability in extent of platelet function inhibition after administration of optimal dose of glycoprotein IIb/IIIa receptor blockers in patients undergoing a high-risk percutaneous coronary intervention
    • G. Danzi, C. Capuano, M. Sesana, L. Mauri, and F. Sozzi Variability in extent of platelet function inhibition after administration of optimal dose of glycoprotein IIb/IIIa receptor blockers in patients undergoing a high-risk percutaneous coronary intervention Am J Cardiol 97 2006 489 493
    • (2006) Am J Cardiol , vol.97 , pp. 489-493
    • Danzi, G.1    Capuano, C.2    Sesana, M.3    Mauri, L.4    Sozzi, F.5
  • 22
    • 65249091961 scopus 로고    scopus 로고
    • Benefits from small molecule administration as compared with abciximab among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: A meta-analysis
    • G. De Luca, G. Ucci, E. Cassetti, and P. Marino Benefits from small molecule administration as compared with abciximab among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-analysis J Am Coll Cardiol 53 2009 1668 1673
    • (2009) J Am Coll Cardiol , vol.53 , pp. 1668-1673
    • De Luca, G.1    Ucci, G.2    Cassetti, E.3    Marino, P.4
  • 23
    • 70450141566 scopus 로고    scopus 로고
    • A comparison of abciximab and small molecule glycoprotein IIb/IIIa inhibitors in patients undergoing primary percutaneous coronary intervention
    • H. Gurm, U. Tamhane, P. Meier, P. Grossman, S. Chetcuti, and E. Bate A comparison of abciximab and small molecule glycoprotein IIb/IIIa inhibitors in patients undergoing primary percutaneous coronary intervention Circ Cardiovasc Interv 2 2009 230 236
    • (2009) Circ Cardiovasc Interv , vol.2 , pp. 230-236
    • Gurm, H.1    Tamhane, U.2    Meier, P.3    Grossman, P.4    Chetcuti, S.5    Bate, E.6
  • 24
    • 0034702175 scopus 로고    scopus 로고
    • Randomized, controlled trials, observational studies, and the hierarchy of research designs
    • J. Concato, N. Shan, and R. Horowitz Randomized, controlled trials, observational studies, and the hierarchy of research designs N Engl J Med 342 2000 1887 1892
    • (2000) N Engl J Med , vol.342 , pp. 1887-1892
    • Concato, J.1    Shan, N.2    Horowitz, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.